Investigators characterized the potential effects of liraglutide, a glucagon-like peptide-1 receptor agonist, on preventing high glucose-induced endothelial dysfunction and excessive mitophagic response.
[Molecular and Cellular Endocrinology]
7992332
{7992332:AAAAAAAA}
apa
50
1
170789
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
